Xiaowei Zhang

Dr. Xiaowei Zhang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2014 in Emergency Medicine Australasia
Verified
Journal Article
Closed access
PDF file
YXYunbei Xiao
Yunbei Xiao
JWJinguo Wang
Jinguo Wang
SCSi Chen
Si Chen
ZWZhigang Wu
Zhigang Wu
JCJian Cai
Jian Cai
XZXiaowei Zhang
Xiaowei Zhang

1 July 2021 in Asian Journal of Andrology
Verified
Journal Article
Open access
YQYuan Quan
Yuan Quan
ZGZi-Rui Gao
Zi-Rui Gao
XDXiang Dai
Xiang Dai
LKLing Kuang
Ling Kuang
MZMin Zhang
Min Zhang
XZXiaowei Zhang
Xiaowei Zhang
Hyaluronic acid injection is becoming a popular way for penile augmentation. However, only few studies and follow-ups have investigated the various complications of hyaluronic acid injection and their corresponding management. In this study, a total of 230 patients who had penile augmentation with hyaluronic acid injection from January 2018 to December 2019 were examined on follow-up for penile girth, complications, and their corresponding management. At 1-month, 3-month, and 6-month postoperative follow-ups, the penile circumference had increased by 2.66 ± 1.24 cm, 2.28 ± 1.02 cm, and 1.80 ± 0.83 cm, respectively. During the entire 6-month follow-up, 4.3% had complications such as subcutaneous bleeding, subcutaneous nodules, and infection. There were no systemic or local allergic reactions among all the patients. All complications were treated accordingly, and no further deterioration or severe sequelae were observed. Although complications of hyaluronic acid injections are mild and rare, these may affect the patient's satisfaction postoperatively. Preoperative redundant prepuce may increase the incidence of penile edema or postoperative gel migration. Standardization of the surgery protocol and elucidation of the effects of other injection parameters are still lacking. Nevertheless, it still highlights the importance of preoperative preparation and surgical technique.

24 October 2019 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
TXTingmin Xu
Tingmin Xu
GZGuoxi Zhang
Guoxi Zhang
WBWenjun Bai
Wenjun Bai
QLQing Li
Qing Li
AYAnpu Yang
Anpu Yang
XZXiaowei Zhang
Xiaowei Zhang
Introduction: Acellular dermal matrix (ADM) is a common filler used widely in clinical practice to increase penile girth for cosmetic reasons, but there are few studies on its complications. Aim: The aim of this study was to investigate and analyze the complications of penile girth enhancement (PGE) with ADM. Methods: The medical records of 78 patients who underwent PGE with ADM between June 2016 and January 2019 were retrospectively reviewed. Main Outcome Measure: Related complications and their subsequent management were summarized and analyzed. Results: 78 patients (mean age 31.14 years [21−66 years]) received PGE with ADM. At the 3-month follow-up, the penile circumference was increased by 1.1 (0.5−2.1) cm on average. There were 47 patients with erectile discomfort, 12 with delayed healing, 10 with unobvious augmentation effect, 8 with wound hematoma, 7 with prepuce edema, 4 with wound infection, and 3 patients with skin necrosis of the dorsal side. 7 patients eventually underwent ADM removal. Clinical Implications: These adverse complications indicate that ADM should be used with caution for PGE. Strength & Limitations: This study adds important data, as there are few published reports on the complications of PGE with ADM. However, this study did not compare postoperative complications with ADM to those seen with other filler material. Conclusion: Even with standardized surgical methods and rigorous postoperative care, complications of PGE using ADM are severe, which indicates that it is not an ideal or safe method for PGE.

8 April 2022 in Asian Journal of Andrology
Verified
Journal Article
Open access
CZChun-Long Zhang
Chun-Long Zhang
YQYuan Quan
Yuan Quan
HLHe Li
He Li
QLQing Li
Qing Li
WBWen-Jun Bai
Wen-Jun Bai
XZXiaowei Zhang
Xiaowei Zhang
There is no well-established procedure for the management of small penis syndrome (SPS), especially when psychological interventions fail. This study aimed at systematically evaluating the physical and psychological benefits of penile augmentation (PA) using injectable hyaluronic acid (HA) gel. Thirty-eight patients receiving PA with HA gel from January 2017 to March 2020 were included and followed up for 1 year. Penile size, erectile function, and psychological burden measured by the Index of Male Genital Image (IMGI), Index of International Erectile Function (IIEF), and Beliefs about Penis Size (BPAS), respectively, were assessed at the beginning and at 1, 3, 6, and 12 months postinjection. The volume of HA gel injected was 21.5 ± 3.7 ml. Compared to baseline data, flaccid penile girth and length significantly increased by 3.41 ± 0.95 cm (P < 0.01) and 2.55 ± 0.55 cm (P < 0.01) at the 1st month postinjection, respectively. At the endpoint, despite attenuations, statistically significant improvements in flaccid penis size were still obtained, namely 2.44 ± 1.14 cm in girth (P < 0.01) and 1.65 ± 0.59 cm in length (P < 0.01). Similarly, erectile penile girth statistically increased by 1.32 ± 1.02 cm (P < 0.01) at the 1st month but were only 0.80 ± 0.54 cm bigger than baseline (P < 0.01) at the endpoint. At the 1st month, the average score of IMGI and the mean score of IIEF statistically increased by 46.2 ± 10.5 (P < 0.01) and 7.6 ± 6.2 (P < 0.01), respectively; the score of BAPS significantly decreased by 18.3 ± 4.5 (P < 0.01). These alterations remained steady during follow-up. Considering the significant penile size improvement, lasting psychological benefit, and low complication rate, PA with HA might serve as an appropriate alternative for patients with SPS.

1 April 2023 in BMC Urology
Verified
Journal Article
Open access
PDF file
KCKewei Chen
Kewei Chen
QLQing Li
Qing Li
TXTao Xu
Tao Xu
XZXiaowei Zhang
Xiaowei Zhang
Background: Hyaluronic acid (HA) injection has become a burgeoning method to treat premature ejaculation (PE) due to its high biocompatibility and structural properties.Purpose: In this study, we proposed a modified technique: injecting hyaluronic acid around coronal sulcus to treat PE, aiming to decrease the complications of hyaluronic acid injection in penis while achieving similar effects.Method: A total of 85 patients who had HA injection from January 2018 to December 2019 were analyzed retrospectively in our study. 31 patients received injection at glans penis and 54 patients received injection around coronal sulcus. Intravaginal ejaculation latency time (IELT) was mainly measured to estimate the efficacy and the severity of complications was assessed between two groups.Results: The mean IELT was 123.0 ± 37.28 s of all patients, 124.7 ± 39.01 s of patients injecting at glans penis and 121.9 ± 36.58 s of patients injecting around coronal sulcus. IELT of all patients increased to 482.1 ± 121.7 s at 1 month, 331.2 ± 81.2 s at 3 month and 280 ± 80.4 s at 6 month. In the group of injecting at glans penis, the incidence of complications is 25.8% and it is 1.9% in the group of injecting around coronal sulcus. No severe complication was reported in both groups.Conclusion: The modified technique of injecting around coronal sulcus decreases complications and it has the potential to become a new injectable technique for treating premature ejaculation.

1 August 2022 in Andrologia
Verified
Journal Article
Closed access
CZChunlong Zhang
Chunlong Zhang
YQYuan Quan
Yuan Quan
YSYuxuan Song
Yuxuan Song
WBWenjun Bai
Wenjun Bai
QLQing Li
Qing Li
XZXiaowei Zhang
Xiaowei Zhang
Glandular augmentation (GA) with hyaluronic acid (HA) is a newly developed, minimally invasive therapy for patients with premature ejaculation (PE); however, evidence supporting its efficacy is scarce. To provide a comprehensive profile of GA with HA gel in managing PE, 184 patients with PE who received GA with HA gel therapy from October 2017 to November 2019 were included and followed up for 1 year. The Fan technique was applied. Intravaginal Ejaculation Latency Time (IELT), Chinese Index of Premature Ejaculation-5(CIPE-5) and Visualised Satisfaction Index (VSI) of sexual experience were assessed at initial and 1-, 3-, 6- and 12-month post injection. A total of 71 patients with primary PE (pPE, 38.6%) and 113 patients with acquired PE (aPE, 61.4%) were enrolled. The mean IELT increased to 100.7 +/- 43.2 s(p < .05) for pPE patients and 359.2 +/- 87.1 s (p < .05) for aPE patients 1-month post injection and remained significantly higher at the end point with acceptable attenuation. The mean CIPE-5 score increased to 17.6 +/- 6.4 (p < .05) in the 1st month and remained steady. The VSI scores increased to 6.6 +/- 1.0 (p < .05) for patients with pPE and 7.7 +/- 1.2 (p < .01) for patients with aPE. Increments in VSI in patients with aPE were significantly higher than those in patients with pPE (p < .01). No severe complications were noted. GA with HA may be an effective and safe method to treat PE. Patients with acquired PE were also more satisfied post treatment.